版本:
中国

BRIEF-Biondvax says approved for grant from Israel's Ministry of Economy and Industry to build facility for commercial scale production of universal flu vaccine

March 30 Biondvax Pharmaceuticals Ltd

* Biondvax pharmaceuticals - approved for grant from Israel's Ministry of Economy and Industry to build facility for commercial scale production of universal flu vaccine

* Biondvax - plans to build mid-sized factory in Jerusalem, with potential capacity to annually produce up to tens of millions of doses of M-001

* Biondvax - five completed phase 1/2 and phase 2 human clinical trials have shown vaccine to be safe and immunogenic to multiple flu strains Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐